GlassScriptPhysician profile
Denise Lora Sweeney
NPI 1841267960
$27,485.48
in general payments reported to CMS, 2019-2025
33 companies · $55.99 in 2025
The $55.99 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $3,633 · 2021: $2,302 · 2022: $957 · 2023: $19K · 2024: $813 · 2025: $55.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $2,143 · Travel and Lodging: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,404.12 |
| Food and Beverage | $2,143.32 |
| Travel and Lodging | $750.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $15,107.40 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Visby Medical, INC. | $9,439.72 | 2022-2023 | Visby Medical Sexual Health Click Test |
| Abbvie INC. | $609.96 | 2019-2024 | Orilissa, Lo Loestrin Fe, Liletta |
| Cytyc Surgical Products, LLC | $500.00 | 2020 | |
| Astellas Pharma US INC | $300.93 | 2020-2024 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $220.04 | 2022-2025 | |
| Daiichi Sankyo INC. | $209.55 | 2020-2024 | Injectafer |
| Pfizer INC. | $130.47 | 2020-2024 | |
| Caldera Medical, INC | $110.76 | 2024 | Desara |
| Myriad Women'S Health, INC. | $95.08 | 2023 | |
| Coopersurgical, INC. | $91.73 | 2020-2024 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $71.43 | 2019-2023 | Bridion |
| Neuronetics, INC. | $65.00 | 2022 | |
| Sumitomo Pharma America, INC. | $58.26 | 2023-2024 | Myfembree |
| Dysis Medical, INC. | $54.83 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $50.81 | 2023-2024 | Nexplanon |
| Becton, Dickinson and Company | $41.22 | 2024 | Bd Onclarity |
| Medtronic, INC. | $39.98 | 2021-2023 | Truclear |
| Therapeuticsmd, INC. | $38.47 | 2019 | |
| Ethicon US, LLC | $37.50 | 2024 | Ethicon, Stratafix |
| Abbott Laboratories | $23.15 | 2021 | |
| Myovant Sciences INC. | $21.81 | 2022 | |
| Evofem Biosciences, INC. | $21.19 | 2023 | Phexxi |
| Molnlycke Health Care US, LLC | $17.89 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.11 | 2019 | |
| Convatec INC. | $15.81 | 2023 | |
| Lilly USA, LLC | $15.38 | 2024 | Zepbound |
| Agile Therapeutics, INC. | $14.53 | 2024 | Twirla |
| Axonics, INC. | $14.51 | 2022 | |
| Sage Therapeutics, LLC | $13.58 | 2024 | |
| Inspire Medical Systems, INC. | $13.56 | 2023 | Inspire |
| Allergan, INC. | $12.41 | 2019 | |
| Lupin INC. | $12.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.